Molecular Minimal Residual Disease in Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a heterogeneous group of clonal hematopoietic stem-cell disorders with a variable response to therapy. Although the majority of patients with newly diagnosed AML have morphologic complete remission after they are treated with intensive induction chemotherapy, relapse…

https://ift.tt/2J3ak6b